Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Lindex esitleb kollektsiooni koostöös kunstnik Emilia Ilkega

Lindex esitleb kollektsiooni koostöös Rootsi kunstnik Emilia Ilkega, kes on tuntud oma mänguliste kompositsioonide ja omanäoliste kujundite poolest. Emilia ja Lindex on koos loonud unikaalse ööriiete kollektsiooni, mis koosneb pehmetest kokkusobivatest riietest nii naistele, lastele kui ka beebidele. „Meil on väga hea meel teha koostööd Emilia Ilkega. Emilial on ainulaadne oskus muuta igapäevased esemed pehmeteks kujunditeks ning luua väikeseid lugusid. Nagu väikesed toad, mis asuvad oma universumis, kõik Emilia loomingulisest mõttemaailmast. Meie koos loodud kollektsioon, mille

SimCorp A/S – Share buyback program completed

Company Announcement no. 53/2021On August 13, 2021 SimCorp A/S announced a share buyback program in compliance with the provisions of Regulation No. 596/2014 of the European Parliament and of the Council on market abuse (the Market Abuse Regulation - MAR) and delegated legislation under MAR. In connection with the program SimCorp A/S announced that it will repurchase shares for an amount of up to EUR 20.0m, to be executed during the period from August 13, 2021 to December 17, 2021. The following transactions have been executed under the program:          Date

Scandinavian ChemoTech's subsidiary Vetiqure AB has initiated TSE treatments on horses

Vetiqure AB, which primarily concentrates on Tumour Specific Electroporation (TSE) for veterinary medicine, has now, together with its partner Evidensia Helsingborg, initiated TSE treatments on horses.The treatment was performed on sarcoids, which are a wart-like form of tumour in the skin of horses. These tumours are common but painful and affect many horses. " We are awaiting more information but are very positive that we are now starting the journey with TSE treatments also in the category of large animals. The market for sarcoids on large animals has great potential in Europe, North

New HI-GENIC mousepad from Speedlink features Polygiene ViralOff to provide hygienic protection for gamers

Speedlink, one of Europe’s leading PC and video game console accessories brands, has launched a new mousepad featuring antimicrobial technology from Swedish firm Polygiene®. The HI-GENIC mousepad is designed for private use at home as well as in lively offices and public spaces. It has a robust yet soft textile surface that is pleasant to use and suitable for all mouse sensors. The mousepad remains in place, even on smooth surfaces, thanks to a non-slip base. To provide hygienic protection for the user, the mousepad is treated with Polygiene ViralOff[TM] – a textile treatment that

Cereno Scientific publishes interim report for Q3 2021

The Board and Chief Executive Officer of Cereno Scientific AB here presents the interim report for Q3, 1 July – 30 September, 2021.Summary of the third quarter, July – September 2021 Cereno Scientific Group Third quarter (1 July – 30 September 2021) · Net Sales were SEK 0 (0) · Result after financial items was SEK -3 356 309 (-3 132 513) · Earnings per share was SEK -0.05 (-0.08) before dilution and SEK -0.02 (-0.07) after dilution · The equity/assets ratio was 89.9% (86.3%) Parent company Third quarter (1 July – 30 September 2021) · Net sales were SEK 0 (0)

Nomination Committee appointed before the annual general meeting of Bioservo 2022

In line with the decision taken during the Annual General Meeting on April 19, 2021, Bioservo’s Chairman of the Board has contacted the company's largest owners to form a nomination committee. Counted as an owner is also a group of two or more shareholders (shareholder group) if they have notified the Chairman of the Board that they wish to participate in the work of the nomination committee together. The following shareholders and representatives are part of the Nomination Committee, in addition to Anders Lundmark, Chairman of the Board: · Runar Bjørklund, nominated by Tellacq AB,

First European sales of generic Tiotropium bromide 18 µg DPI, developed by Phargentis

(November 10, 2021) Tiotropium bromide 18 µg Dry Powder Inhaler developed by Phargentis has been launched in Europe. It is the first generic product approved in the EU with precisely the same strength and same delivered dose as Spiriva®Handihaler®, the global first-line treatment for COPD. This generic equivalent has been delivered to the UK, Norway, Spain and the Netherlands, with formal pricing and substitution agreements agreed within those markets. Global turnover for Spiriva®Handihaler® in 2020 exceeded 2.5 bUSD (IQVIA).In May 2021 the generic Tiotropium bromide 18µg DPI, developed by

BioStock: Ultimovacs progresses on several fronts

The year’s third quarter saw Norwegian immuno-oncology developer Ultimovacs make several key advancements. Not only has the company progressed with its phase I clinical development of universal cancer vaccine UV1, but it has also announced the initiation of a fifth phase II trial with the candidate. To top things off, among other news, Ultimovacs was awarded dual Fast Track designation for UV1 from the FDA and raised 270 MNOK in a private placement.Read the article at biostock.se : https://www.biostock.se/en/2021/11/ultimovacs-progresses-on-several-fronts/

ORGANOCLICK AB (PUBL) PUBLISH INTERIM REPORT FOR Q3 2021

During the third quarter, we saw clear operational improvements. Not only did sales increase by 13.5 (27.7)percent to MSEK 22.6 (19.9), but we also concluded new agreements with both XXL Sverige for OrganoTex®and with Bergs timber UK for OrganoWood® timber. We were also able to reduce our high costs of productiongradually over the quarter, which arose as a consequence of capacity shortages during the second quarter.At the end of the quarter, our new fully automated filling machine became operational. This will increase ourproductivity and capacity for 2022. During 2021, our sales

Veoneer Files Definitive Proxy in connection with SSW and Qualcomm Merger Agreement

Stockholm, Sweden, November 16, 2021: The automotive technology company Veoneer, Inc. (NYSE: VNE and SSE: VNE SDB), today announced that it has filed a definitive proxy statement with the Securities and Exchange Commission (the “SEC”) ahead of a Special Meeting of Veoneer stockholders.The Special Meeting is scheduled to take place on December 16, 2021 and will ask stockholders to, among other things, consider and vote on a proposal to adopt the previously announced merger agreement, dated October 4, 2021, by and among Veoneer, SSW HoldCo LP, SSW Merger Corp and QUALCOMM Incorporated (NASDAQ:

Sveaskog partner up with AirForestry

Sveaskog has been an important partner from an early stage in AirForestry's development. When entering the company's next development phase the cooperation is now deepening ahead. Sveaskog owns 14 percent of the Swedish forest land and thus is the country's largest forest owner. This makes them an important player in forestry with great influence over its development. AirForestry is an innovative company that uses electric drones to create a sustainable, long-term and efficient forestry for the future. From the start, Sveaskog has been an important partner who assisted with key

Update on regulatory approvals relating to the voluntary tender offer for Sbanken ASA

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INTO OR WITHIN CANADA, AUSTRALIA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL Oslo, 16 November 2021 Reference is made to the offer document dated 23 April 2021 (the "Offer Document") and subsequent stock exchange announcements for the recommended voluntary offer by DNB Bank ASA (the "Offeror") to acquire all outstanding shares in Sbanken ASA (the "Company") not already owned by the Offeror (the "Offer"). Further

LINK Mobility to strengthen conversational messaging capabilities by acquiring Italian-based NLP/AI Chatbot, Matelab Srl (“Xenioo”)

Oslo, Norway – 16 November 2021, LINK Mobility (LINK), a leading Communications Platform as a Service (CPaaS) provider, has entered into a definitive agreement to acquire Italian-based Matelab Srl. This acquisition will strengthen LINK’s conversational messaging capabilities with CCaaS, Natural Language Processing (NLP), and Artificial Intelligence (AI) chatbot competencies and will immediately bolster its omnichannel offerings.The company’s core offerings are the proprietary advanced conversational AI and NLP-driven software, including advanced conversational chatbot Xenioo, and the

New technology for production of green hydrogen will support future energy needs

Semcon is collaborating with Norwegian company Hystar to develop new technology for hydrogen gas production. The project aims to increase the amount of hydrogen gas that can be produced through electrolysis by over 150% compared to current electrolyser technology – without using more energy. To produce renewable green hydrogen gas is identified as a priority by the EU and crucial to achieving the European Green Deal.“The electrolyser technology we’re developing together will allow Hystar to produce highly energy efficient electrolyser stacks, with the potential to reduce the capital cost of

Arctic Bioscience – Strengthening IP platform with new patent for method for utilizing immature herring roe

Arctic Bioscience, a biotech company with a pre-commercial pharmaceutical business and a commercial nutraceutical business, is pleased to announce it is granted a U.S. patent[1 ]with a new method related to type II diabetes. The patent claims protection for a method utilizing a lipid composition with a phospholipid extract from immature herring roe. The method is based on the same patented technology that is being used in the company’s two ongoing development programs for psoriasis and brain development.“Arctic Biosciences pharmaceutical development programs are based on the company’s

XNK Therapeutics adds three scientific advisors to bolster platform technology

XNK Therapeutics AB (“XNK”) today announced the strengthening of the company’s expertise by the appointment of Ola Landgren, M.D., Ph.D., Fredrik Schjesvold M.D., Ph.D. and Johan Lund M.D., Ph.D. These scientific advisors are key to the company’s plan to further expand the scope of its proprietary technology platform of natural killer (NK) cell therapies within plasma cell disorders and hematological malignancies.Dr. Ola Landgren joins with more than 30 years of medical experience. He serves as Professor of Medicine and Chief of Myeloma Program and Experimental Therapeutics Program at

Ahlgood invests in Swedish cultural heritage as a plant-based protein source

Greenfood-owned Ahlströms is continuing to develop its range of plant-based alternatives under the Ahlgood brand. The products are based on traditional, Swedish-grown, organic and KRAV-labelled produce grown in a gentle way. Falafel on gray and autumn peas, lentil bites, and organic legume mince on quinoa and gray pea are some examples. Vegetarian food and plant-based products continue to show strong growth in the European market. To meet the increased demand, Greenfood is investing in expanding its range of plant-based products. The new Ahlgood brand specialises entirely in plant-based

Agnafit Bidco further extends the acceptance period and waives the conditions for completion of the public offer to the shareholders of Sobi, except for the acceptance level condition

This announcement is not an offer, whether directly or indirectly, in Australia, Hong Kong, Japan, New Zealand or South Africa or in any other jurisdiction where such offer pursuant to legislation and regulations in such relevant jurisdiction would be prohibited by applicable law. Shareholders not resident in Sweden who wish to accept the Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders should refer to the offer restrictions included in the section titled "Important information" at the end of this announcement and in

COSEL announces 330% peak power 1kW open-frame power supplies for medical and industrial applications

• 330% peak power for up to 3,000 milliseconds• EN62477-1 OVC III certified for safety in industrial applications• Suitable for medical Body Floating (BF) applications• Small and compact PCB layout optimized for free-air convection• High efficiency to reduce energy consumption• 5 year standard warranty COSEL Co, Ltd (6905: Tokyo) today announced the introduction of 1,000W free-air convection cooling power supplies, the AEA1000F series. With demanding applications in mind, the AEA1000F is able to deliver 330% peak power for a period of up to 3,000 milliseconds. Designed for

Faron to Present at Jefferies Conference 2021

Faron Pharmaceuticals Ltd. (“Faron”) Faron to Present at the Jefferies London Healthcare Conference Press Release, November 16, 2021 at 02:00 AM (EDT) / 07:00 AM (GMT) / 09:00 AM (EET) TURKU, FINLAND / BOSTON, MA – Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system to tackle cancer and inflammation, today announced that Yrjö Wichmann, Vice President of Financing and Investor Relations, will present at the Jefferies London Healthcare

Aiforia achieves CE-IVD mark for clinical PD-L1 AI model in lung cancer diagnostics

Aiforia announces the CE-IVD mark of its Aiforia® Clinical AI Model for Lung Cancer; PD-L1 for assisting pathologists in the fast and accurate primary diagnosis of lung cancer. This latest AI model expands Aiforia’s portfolio of clinical diagnostics solutions for pathology.Worldwide the most common cause of cancer mortality in 2020 was lung cancer, with an estimated 1.80 million deaths occurring¹. Fortunately, immunotherapies are increasing in prominence and efficacy². A popular target for these novel therapeutics is PD-L1, a vital biomarker indicating cancer progression³. The calculation

The construction of wooden apartment buildings reflects the long tradition of timber-based construction

YIT Corporation News 16 November 2021 at 09:00 a.m.The Rantapuisto wooden apartment building pilot project will be completed by the end of 2021 in Tampere’s Niemenranta district. What advantages does timber-based module construction offer?  The convenience of living in an apartment building, the eco-friendly and cosy qualities of a wooden building, heated economically with geothermal heat, on the shore of Lake Näsijärvi. Severi Kohtala from Tampere is one of the 23 lucky apartment owners of the wooden apartment building As Oy Tampereen Rantapuisto.  Kohtala was looking for an

Insr: Invitation to presentation of Q3 2021 results

Insr Insurance Group ASA will publish results for the third quarter 2021 on www.newsweb.no and www.insr.io on Wednesday November 17th, 2021.  Niclas Ward (CEO) and Gunnar Aarnes (External consultant) will present the results on November 17th, at 08:30 CET, through participative webcast only. Click on the following link to follow the presentation: Webcast presentation LIVE, Wednesday, 17th of November 08:30 CET 

There are no items matching the current filter
There are no more items matching the current filter
Back to top